Trilegal and Canadian law firm Osler, Hoskin & Harcourt advised the largest Canadian contract research organisation (CRO) JSS Medical Research on its Rs 9.5 crore ($1.5m) buy of CRO Max Neeman Medical International which was advised by AZB & Partners.
Trilegal partner Charandeep Kaur, counsel Ramakant Rai and associate Jatin Vyas, and Osler Montreal-based managing partner Shahir Guindi and associate Geneviève Burdon acted for JSS
AZB Delhi partners Anil Kasturi and Niladri Maulik and associate Siddharth Khanna acted for Max.
MNMI, part of the Max India group which split three-way , provides clinical development services to small, mid-size and global pharmaceutical, biotech and medical device companies, according to VCCircle.
- how many firms involved? Do we know all partners?
- how big is the deal?
- how interesting is the sector / deal / cross-border?
- is it an exclusive deal?
- how recent is it?
- do we have any other deals currently sitting there awaiting publication?
- has it been reported in the business papers?
- is it a deal by a start-up or other firm we haven't reported on very often before?